Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-01-25 | ALPINE IMMUNE SCIENCES, INC. | Rickey James Paul
(See Remarks) |
S | Common Stock | D | 118000 | $22.00 - $25.00 | $2,751,021 |
| 2024-01-25 | ALPINE IMMUNE SCIENCES, INC. | Rickey James Paul
(See Remarks) |
M | Common Stock | A | 118000 | $6.51 - $11.31 | $979,379 |
| 2024-01-18 | ALPINE IMMUNE SCIENCES, INC. | Decheng Capital M...
(AtLeastTenPercentOwner) |
X | Common Stock | A | 1234636 | $12.74 - $12.74 | $15,729,262 |
| 2024-01-18 | ALPINE IMMUNE SCIENCES, INC. | Cui Xiangmin
(Director) |
X | Common Stock | A | 1234636 | $12.74 - $12.74 | $15,729,262 |
| 2024-01-11 | ALPINE IMMUNE SCIENCES, INC. | OrbiMed Genesis G...
(Director) |
X | Common Stock | A | 145251 | $12.74 - $12.74 | $1,850,497 |
| 2024-01-11 | ALPINE IMMUNE SCIENCES, INC. | Thompson Peter A.
(Director) |
X | Common Stock | A | 145251 | $12.74 - $12.74 | $1,850,497 |
| 2024-01-04 | ALPINE IMMUNE SCIENCES, INC. | GOLD MITCHELL
(Executive Chairman and CEO) |
A | Common Stock | A | 96000 | $0.00 - $0.00 | $0 |
| 2023-12-19 | ALPINE IMMUNE SCIENCES, INC. | Rickey James Paul
(See Remarks) |
S | Common Stock | D | 15213 | $19.21 - $19.21 | $292,221 |
| 2023-12-19 | ALPINE IMMUNE SCIENCES, INC. | Rickey James Paul
(See Remarks) |
M | Common Stock | A | 15213 | $5.02 - $5.02 | $76,369 |
| 2023-12-14 | ALPINE IMMUNE SCIENCES, INC. | Rickey James Paul
(See Remarks) |
S | Common Stock | D | 58787 | $19.00 - $19.09 | $1,120,991 |
| 2023-12-14 | ALPINE IMMUNE SCIENCES, INC. | Rickey James Paul
(See Remarks) |
M | Common Stock | A | 58787 | $5.02 - $5.02 | $295,109 |
| 2023-12-11 | ALPINE IMMUNE SCIENCES, INC. | Topper James N
(Director) |
X | Common Stock | A | 145251 | $12.74 - $12.74 | $1,850,497 |
| 2023-12-08 | ALPINE IMMUNE SCIENCES, INC. | GOLD MITCHELL
(Executive Chairman and CEO) |
S | Common Stock | D | 118000 | $17.08 - $17.32 | $2,037,834 |
| 2023-12-12 | ALPINE IMMUNE SCIENCES, INC. | GOLD MITCHELL
(Executive Chairman and CEO) |
M | Common Stock | A | 8613 | $0.45 - $0.45 | $3,875 |
| 2023-12-04 | ALPINE IMMUNE SCIENCES, INC. | Rickey James Paul
(See Remarks) |
S | Common Stock | D | 70811 | $16.01 - $16.08 | $1,137,228 |
| 2023-12-04 | ALPINE IMMUNE SCIENCES, INC. | Rickey James Paul
(See Remarks) |
M | Common Stock | A | 70811 | $3.23 - $3.23 | $228,718 |
| 2023-11-30 | ALPINE IMMUNE SCIENCES, INC. | Rickey James Paul
(See Remarks) |
S | Common Stock | D | 700 | $16.00 - $16.00 | $11,200 |
| 2023-11-30 | ALPINE IMMUNE SCIENCES, INC. | Rickey James Paul
(See Remarks) |
M | Common Stock | A | 700 | $3.23 - $3.23 | $2,261 |
| 2023-11-06 | ALPINE IMMUNE SCIENCES, INC. | Rickey James Paul
(See Remarks) |
S | Common Stock | D | 18003 | $16.03 - $16.03 | $288,553 |
| 2023-11-06 | ALPINE IMMUNE SCIENCES, INC. | Rickey James Paul
(See Remarks) |
M | Common Stock | A | 10989 | $3.23 - $3.23 | $35,494 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |